EPISODE · Apr 9, 2006 · 49 MIN
ASFH Anecortave vs Verteporforin
from As Seen From Here
Paper Discussed: Slakter JS, Bochow TW, D'Amico DJ, Marks B, Jerdan J, Sullivan EK, Robertson SM, Slakter JS, Sullins G, Zilliox P; Anecortave Acetate Clinical Study GroupAnecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degenerationOphthalmology. 2006 January;113(1):p3-13Guest: Jason Slakter, MDClinical Professor of Ophthalmology New York University School of MedicineNew York, New York
Embed this episode
NOW PLAYING
ASFH Anecortave vs Verteporforin
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.